Explore News By Topic
04/28/2020
Major Trial Shows Breast Cancer Drug Can Hit Prostate Cancer Achilles Heel
Olaparib, licensed for breast and ovarian cancer, is effective for some men with prostate cancer too Drug better than targeted hormone therapy in cancers with weaknesses in repairing their DNA Major clinical trial heralds approval as first gene-targeted drug in prostate cancer A drug already licensed for the treatment of... Read More
04/14/2020
Prostate Cancer Foundation and MIT Researcher Develops Revolutionary Re-Useable Personal Protective Mask to Battle COVID-19
WHAT: To combat the short supply and high demand for the personal protective equipment (PPE) needed to safeguard medical professionals and first responders in the battle against the COVID-19 global crisis, Prostate Cancer Foundation (PCF) Young Investigator and Massachusetts Institute of Technology (MIT) researcher and physician, James Byrne, M.D., Ph.D.,... Read More
03/25/2020
The Second Annual PCF Black History Month Assist Challenge sets new Fundraising Record by raising more than $500,000 for Prostate Cancer Research
LOS ANGELES, Calif., March 25, 2020 – In its sophomore year, the Second Annual Prostate Cancer Foundation Black History Month Assist Challenge more than tripled its fundraising efforts, compared to 2019, by raising more than $500,000 to combat prostate cancer, a disease that affects more than three million men in... Read More
03/22/2020
Molecular Imaging Could Transform Management of People with Aggressive Cancer
VICTORIA, Australia, March 22, 2020: A medical imaging technique known as PSMA PET/CT that provides detailed body scans while detecting levels of a molecule associated with prostate cancer could help doctors better tailor treatments for their patients, by determining the extent of disease spread at the time of diagnosis, a randomised... Read More
03/18/2020
Kristen Bell Selects the Winners of the Prostate Cancer Foundation’s 3rd Annual True Love Contest
LOS ANGELES, Calif., March 18, 2020 – The Prostate Cancer Foundation (PCF) and actress Kristen Bell announced today, the winners of the 3rd Annual TRUE Love Contest that honors caregivers and supporters of prostate cancer patients. From more than a hundred inspirational stories, Bell chose two heartfelt stories – one... Read More
02/13/2020
Cleveland Clinic Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer
February 13, 2020, CLEVELAND: In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that the a testosterone-related genetic variant – HSD3B1(1245C) – is associated with more aggressive disease and shorter survival in men with metastatic prostate cancer. This study – the first clinical trial validation of the... Read More
02/04/2020
The Prostate Cancer Foundation Recruits NBA and NHL Teams to Join Forces for the 2nd Annual PCF Black History Month Assist Challenge
LOS ANGELES, Calif., February 4, 2020 – The Prostate Cancer Foundation (PCF) has drafted teams from the NBA and NHL to help fight prostate cancer with the 2nd Annual PCF Black History Month Assist Challenge. Teams participating during February include Atlanta Hawks, Brooklyn Nets, Chicago Bulls, Detroit Pistons, Indiana Pacers,... Read More
01/29/2020
The Prostate Cancer Foundation and Kristen Bell Honor Caregivers with its 3rd Annual True Love Contest
LOS ANGELES, Calif., January 29, 2020 – Beginning February 1st, the Prostate Cancer Foundation (PCF) will launch its 3rd Annual TRUE Love contest to honor family and caregivers for their diligent work in caring for their loved ones living with prostate cancer. TRUE pays tribute to the unsung heroes –... Read More
12/16/2019
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
December 16, 2019 – Today the U.S. Food and Drug Administration (FDA) approved a new use for enzalutamide (Xtandi®) for the treatment of metastatic hormone-sensitive (aka, “castration-sensitive”) prostate cancer (mHSPC). Enzalutamide has previously been FDA-approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). PCF funded... Read More
12/16/2019
Winship study sheds light on immune control of cancer
Issued by: Emory University Woodruff Health Sciences Center New findings could provide doctors with vital clues about how the immune system prevents cancer from recurring. The study from Winship Cancer Institute of Emory University looked at whether immune cells were present in tumor samples removed from patients with kidney and... Read More